Hormone prevention strategies for breast, endometrial and ovarian cancers

LW Rice - Gynecologic Oncology, 2010 - Elsevier
The development of effective prevention strategies for breast, endometrial and ovarian
cancers (CA), based on hormonal responsiveness, is a paramount opportunity in the care of …

Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence

A Alonso, CJ Clark - Journal of the neurological sciences, 2009 - Elsevier
Multiple sclerosis (MS) is more frequent in women than in men, suggesting that sex
hormones could play a role in the development of MS. For this reason, several studies have …

Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India

D Shah, M Patil… - Journal of human …, 2018 - journals.lww.com
Objective: To provide consensus recommendations for health-care providers on the use of
oral contraceptive pills (OCPs) in polycystic ovarian syndrome (PCOS) women in India …

Breast cancer risk factors among Ugandan women at a tertiary hospital: a case-control study

M Galukande, H Wabinga, F Mirembe, C Karamagi… - Oncology, 2016 - karger.com
Abstract Background: Although East Africa, like other countries in sub-Saharan Africa, has a
lower incidence of breast cancer than high-income countries, the disease rate is rising …

Contraception for the perimenopausal woman

A Linton, A Golobof, LP Shulman - Climacteric, 2016 - Taylor & Francis
Perimenopause, or the menopause transition, is a time in a woman's life that bridges her
reproductive years through to the non-surgical cessation of ovulation, or menopause. For …

The effect of hormonal contraception on the risk of breast cancer: A review

MV Iurova, EA Mezhevitinova… - Journal of Modern …, 2023 - modernonco.orscience.ru
Hormonal-induced changes in the breast occur due to both endogenous and exogenous
sex hormones. For two decades, the safety of hormonal contraceptives (HC) in terms of their …

The risk of breast, cervical, endometrial and ovarian cancer in oral contraceptive users

M Veljković, S Veljković - Medicinski pregled, 2010 - doiserbia.nb.rs
Introduction. Oral contraceptives, mainly combined monophasic pills, are widely used by
young women who expect their physicians to prescribe them safe drugs which will not harm …

Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?

M Fanta - Gynecological Endocrinology, 2013 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting women of fertile
age. It is associated with several risk factors and long-term health consequences. Chronic …

New regimens with combined oral contraceptive pills–moving away from traditional 21/7 cycles

CM Read - The European Journal of Contraception & …, 2010 - Taylor & Francis
The practice of extending combined oral contraceptive use (COC) and eliminating or
reducing the hormone free interval has been in use for many years. More recently a range of …

50 years of “The Pill”: celebrating a golden anniversary

A Szarewski, D Mansour, LP Shulman - BMJ Sexual & Reproductive …, 2010 - srh.bmj.com
The past 50 years have seen great advances in combined oral contraceptives (COCs) that
have resulted in reduced risks of adverse events and improved cycle control. The most …